Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Optical 92
Drug Discovery 90
Optical Disorders Drugs 87
Oncology Drugs 85
Immune Disorders Drugs 79
Cardiovascular Drugs 53
Musculoskeletal Disorders Drugs 49
Biopharmaceuticals 47
Dermatological Drugs 47
Clinical Trials 43
Pharmaceuticals 38
Genomics 34
Endocrine and Metabolic Disorders Drugs 33
Biotechnology 30
Infectious Diseases Drugs 25
Skin Cancer Drugs 25
Central Nervous System Drugs 22
Respiratory Drugs 21
Allergy Drugs 20
Allergy and Immunology 17
Gastrointestinal Drugs 17
Infusions and Injectables 15
Hematological Drugs 15
Lung Cancer Drugs 12
Leukemia Drugs 12
Dermatology 12
Oncology 11
Diagnostics 10
Asthma Drugs 10
Lymphoma Drugs 9
Analgesics 8
Needles and Syringes 8
Pharmaceutical Manufacturing 8
Company Reports 7
Therapeutic Area 7
Biosimilars and Biosuperiors 7
Enzymes 6
Vaccines 6
Prostate Cancer Drugs 5
Ovarian Cancer Drugs 5
Brain Cancer Drugs 5
Liver and Kidney Disorders Drugs 5
Immunosuppressive Drugs 5
Pharmaceutical Intermediates 4
Pulmonary Medicine 4
Proteomics 4
Cardiovascular Devices 4
Transdermal and Transmucosal Drug Delivery 4
Medical Devices 4
Drug Delivery 4
Anti-Obesity Drugs 4
Gastroenterology 4
Colon Cancer Drugs 3
Cervical Cancer Drugs 3
Kidney Cancer Drugs 3
Laboratory Equipment 3
Sexual and Reproductive Health Drugs 3
Drugs by Therapeutic Area 2
Liver Cancer Drugs 2
Diabetes Drugs 2
Healthcare Services 2
Infectious Disease Testing 2
Cough and Cold Drugs 2
Animal Healthcare/Veterinary 2
Hematology 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Thyroid Cancer Drugs 2
Pediatrics 2
Neurology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Laboratory Testing 1
Managed Care 1
Diabetes Devices 1
Stem Cells 1
Blood Banking 1
Respiratory Devices 1
Biomarkers 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Uterine Cancer Drugs 1
Nanomedicine 1
Cardiology 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Bronchitis Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



280 reviews

819 Results (Page 3 of 41)
- Relevance
  Sort by

Global Scleroderma Diagnostics & Therapeutics Market by Diagnostic Tests (Blood Tests, Imaging, Pulmonary Function Tests), Drug Type (Calcium Channel Blockers, Chelating Agents, Corticosteroids), Therapeutics, Indication - Forecast 2024-2030

 Report
March 2024
186 Pages
Global

From

€3277EUR$3,374USD£2,827GBP

€3641EUR$3,749USD£3,141GBP

Global Natural Killer Cell Therapeutics Market by Therapeutics (NK Cell Directed Antibodies, NK Cell Therapies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), Application, End User - Forecast 2024-2030

 Report
March 2024
184 Pages
Global

From

€3277EUR$3,374USD£2,827GBP

€3641EUR$3,749USD£3,141GBP

Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
120 Pages
Global

From

€3399EUR$3,500USD£2,933GBP

Global Gout Therapeutics Market by Drug Class (Colchicine, Corticosteroids, NSAIDs), Treatment (Uricosuria Medication, Xanthine Oxidase Inhibitor), Route of Administration, Application - Forecast 2024-2030

 Report
March 2024
185 Pages
Global

From

€3277EUR$3,374USD£2,827GBP

€3641EUR$3,749USD£3,141GBP

Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape

 Report
March 2023
182 Pages
Global

From

€1844EUR$1,899USD£1,591GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Skin Cancer Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
120 Pages
Global

From

€4614EUR$4,750USD£3,980GBP

Global Anti-CD20 Monoclonal Antibodies (mABs) Market 2024-2028

 Report
October 2023
161 Pages
Global

From

€2428EUR$2,500USD£2,095GBP

Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures

 Report
May 2019
385 Pages
Global

From

€4370EUR$4,499USD£3,770GBP

Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030

 Report
January 2020
410 Pages
Global

From

€4758EUR$4,899USD£4,105GBP

Pediatric Respiratory Disease Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
115 Pages
Global

From

€4614EUR$4,750USD£3,980GBP

Global Uveitis Drugs Market 2022-2026

 Report
June 2022
120 Pages
Global

From

€2428EUR$2,500USD£2,095GBP

Axial Spondyloarthritis (axSpA) Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4856EUR$5,000USD£4,189GBP

Psoriatic Arthritis Treatment Global Market Report 2024

 Report
February 2024
250 Pages
Global

From

€4856EUR$5,000USD£4,189GBP

Retinal Biologics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

 Report
November 2023
182 Pages
Global

From

€4759EUR$4,900USD£4,106GBP

Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030

 Report
October 2019
302 Pages
Global

From

€4370EUR$4,499USD£3,770GBP

Uveitis Drugs Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

 Report
October 2023
190 Pages
Global

From

€4759EUR$4,900USD£4,106GBP

Global Uveitis Treatment Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

 Report
February 2024
191 Pages
Global

From

€3497EUR$3,600USD£3,016GBP

Localized Scleroderma - Pipeline Insight, 2024

 Clinical Trials
April 2024
60 Pages
Global

From

€1943EUR$2,000USD£1,676GBP

Arthritis Monoclonal Antibodies Global Market Report 2024

 Report
February 2024
250 Pages
Global

From

€4856EUR$5,000USD£4,189GBP

Conjugated Monoclonal Antibodies Global Market Report 2024

 Report
February 2024
250 Pages
Global

From

€4856EUR$5,000USD£4,189GBP

819 Results (Page 3 of 41)
- 1
- 2
- 3
- 4
- 5

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.